Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58,612 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy.
Ribas A, Glaspy JA, Lee Y, Dissette VB, Seja E, Vu HT, Tchekmedyian NS, Oseguera D, Comin-Anduix B, Wargo JA, Amarnani SN, McBride WH, Economou JS, Butterfield LH. Ribas A, et al. Among authors: lee y. J Immunother. 2004 Sep-Oct;27(5):354-67. doi: 10.1097/00002371-200409000-00004. J Immunother. 2004. PMID: 15314544 Clinical Trial.
Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanoma.
Butterfield LH, Comin-Anduix B, Vujanovic L, Lee Y, Dissette VB, Yang JQ, Vu HT, Seja E, Oseguera DK, Potter DM, Glaspy JA, Economou JS, Ribas A. Butterfield LH, et al. Among authors: lee y. J Immunother. 2008 Apr;31(3):294-309. doi: 10.1097/CJI.0b013e31816a8910. J Immunother. 2008. PMID: 18317358 Free PMC article. Clinical Trial.
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides.
Butterfield LH, Ribas A, Dissette VB, Lee Y, Yang JQ, De la Rocha P, Duran SD, Hernandez J, Seja E, Potter DM, McBride WH, Finn R, Glaspy JA, Economou JS. Butterfield LH, et al. Among authors: lee y. Clin Cancer Res. 2006 May 1;12(9):2817-25. doi: 10.1158/1078-0432.CCR-05-2856. Clin Cancer Res. 2006. PMID: 16675576 Clinical Trial.
Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma.
Comin-Anduix B, Lee Y, Jalil J, Algazi A, de la Rocha P, Camacho LH, Bozon VA, Bulanhagui CA, Seja E, Villanueva A, Straatsma BR, Gualberto A, Economou JS, Glaspy JA, Gomez-Navarro J, Ribas A. Comin-Anduix B, et al. Among authors: lee y. J Transl Med. 2008 May 1;6:22. doi: 10.1186/1479-5876-6-22. J Transl Med. 2008. PMID: 18452610 Free PMC article. Clinical Trial.
Natural killer T cells in advanced melanoma patients treated with tremelimumab.
Ibarrondo FJ, Yang OO, Chodon T, Avramis E, Lee Y, Sazegar H, Jalil J, Chmielowski B, Koya RC, Schmid I, Gomez-Navarro J, Jamieson BD, Ribas A, Comin-Anduix B. Ibarrondo FJ, et al. Among authors: lee y. PLoS One. 2013 Oct 22;8(10):e76829. doi: 10.1371/journal.pone.0076829. eCollection 2013. PLoS One. 2013. PMID: 24167550 Free PMC article. Clinical Trial.
58,612 results
You have reached the last available page of results. Please see the User Guide for more information.